Organizations Filed Purposes:
THE BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION OF CANCER. ADDITIONALLY, KARMANOS PROMOTES, ENCOURAGES, AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENT AND PREVENTION OF CANCER. ESSENTIAL CANCER MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY.
THE BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION OF CANCER.
INPATIENT: HEALTH CARE DELIVERY & MANAGEMENT: BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION OF CANCER. ADDITIONALLY, KARMANOS PROMOTES, ENCOURAGES, AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENT AND PREVENTION OF CANCER. ESSENTIAL CANCER MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY. FROM OCTOBER 2018 TO SEPTEMBER 2019, KARMANOS HAD 24,154 PATIENT DAYS AND 3,033 DISCHARGES FOR AN AVERAGE LENGTH OF STAY OF 7.96 DAYS. IN ADDITION, THERE WERE 284 BONE MARROW TRANSPLANT CASES, 862 INPATIENT SURGICAL CASES, AND 2,869 INPATIENT IMAGING CASES.
AMBULATORY SERVICES: THE BARBARA ANN KARMANOS CANCER HOSPITAL PROVIDED MEDICAL SERVICES TO CANCER PATIENTS INCLUDING RADIATION ONCOLOGY, CHEMOTHERAPY, BONE MARROW TRANSPLANT, MAMMOGRAPHY AND HEMATOLOGY CONSULTATIVE, DIAGNOSTIC AND TREATMENT SERVICES. ESSENTIAL CANCER AND MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY. FROM OCTOBER 2018 TO SEPTEMBER 2019, THE FOLLOWING OUTPATIENT STATISTICS WERE REPORTED: CLINICAL VISITS OF 53,298; INFUSION PATIENTS OF 26,503; IMAGING PROCEDURES OF 62,189; PHERESIS PATIENTS TOTALLED 786; INPATIENT AND OUTPATIENT RADIATION ONCOLOGY PROCEDURES OF 21,195 AND OUTPATIENT SURGICAL CASES OF 1,738.
THE BARBARA ANN KARMANOS CANCER HOSPITAL PROMOTES, AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENTS AND PREVENTION OF CANCER. PHASE 1 CLINIC VISISTS OF 181; PHASE 1 INFUSION PATIENT VISITS OF 4,340. AT SEPTEMBER 30, 2019, KCC HAD 344 ACTIVE CLINICAL DRUG TRIALS; 714 PATIENTS WILLING TO PARTICIPATE OF WHICH 429 WERE ELIGIBLE AND REGISTERED AS PARTICIPANTS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Natasha Robinette | RADIOLOGIST | 40 | $632,661 |
| Hussein Aoun | RADIOLOGIST | 40 | $569,494 |
| Alit Amit-Yousif | RADIOLOGIST | 40 | $556,191 |
| Sunil Bajaj | RADIOLOGIST | 40 | $502,379 |
| Jason Domina | RADIOLOGIST | 40 | $494,635 |
| Brian Gamble | TREASURER, CFO | 20 | $376,292 |
| Kathleen Carolin | VP, CHIEF NURSING OFFICER | 40 | $245,880 |
| Christopher D Graunstadt | VP, OPERATIONS | 40 | $180,020 |
| George H Yoo Md | CHIEF MEDICAL OFFICER | 40 | $124,057 |
| Larry Flaherty Md | BOARD MEMBER | 1 | $0 |
| David W Drews | BOARD MEMBER | 1 | $0 |
| Jack Sobel Md | BOARD MEMBER | 1 | $0 |
| Daniel Ret | BOARD MEMBER | 1 | $0 |
| Phil Incarnati | BOARD MEMBER | 1 | $0 |
| Rev Fr S Scott Hunter | BOARD MEMBER | 1 | $0 |
| Richard M Gabrys | BOARD MEMBER | 1 | $0 |
| Myron Frasier | BOARD MEMBER | 1 | $0 |
| Karen Cullen | BOARD MEMBER | 1 | $0 |
| Jim Bennethum | BOARD MEMBER | 1 | $0 |
| Gerold Bepler Md Phd | BOARD MEMBER/PRESIDENT KCI | 20 | $0 |
| Justin F Klamerus Md | PRESIDENT KCC | 40 | $0 |
| Timothy Monahan | VICE CHAIR | 1 | $0 |
| Tom Kalas | CHAIR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042179349301514_public.xml